Status:

COMPLETED

CONtrolling Disease Using Inexpensive IT - Hypertension in Diabetes

Lead Sponsor:

University of Massachusetts, Worcester

Collaborating Sponsors:

Reliant Medical Group

University of Massachusetts, Amherst

Conditions:

Hypertension

Diabetes Mellitus

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

This project will develop and test a low-cost approach to using health information technology and home monitoring aimed at improving care for chronic conditions, with low barriers to adoption in a wid...

Detailed Description

This project will develop and test a low-cost approach to using health information technology (HIT), aimed at improving the effectiveness and cost-effectiveness of care for chronic health conditions t...

Eligibility Criteria

Inclusion

  • diagnoses of both diabetes mellitus (MODIFICATION 2/13: prediabetes) and hypertension
  • uncontrolled hypertension (mean of up to most recent 3 clinic BPs in previous 6 months with SBP\>=145 and/or DBP\>=85) AND mean of 3 readings taken at intake visit meeting same criterion

Exclusion

  • end-stage renal disease
  • management of blood pressure by provider other than primary care provider (PCP)
  • pregnancy/gestational diabetes
  • terminal illness
  • diagnosed or probable (based on screen) dementia
  • active psychosis
  • moderate-severe mental retardation
  • indication by PCP that patient would be inappropriate for study
  • planning to leave Reliant Medical Group (formerly Fallon Clinic) during the coming year
  • MODIFICATIONS: due to a smaller pool of eligible participants and lower enrollment than anticipated, eligibility for the study has been expanded as of February 2013 to include persons with "prediabetes," defined by either a coded diagnosis of abnormal glucose (International Classification of Diseases \[ICD\] 9-CM codes 790.2x) or a hemoglobin A1c laboratory value from 6.0%-6.4%. For this group, the DBP eligibility criterion will be a mean, as defined above, of \>=95, as target BP for this group is 140/90, not 140/80.

Key Trial Info

Start Date :

August 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2015

Estimated Enrollment :

196 Patients enrolled

Trial Details

Trial ID

NCT01416766

Start Date

August 1 2011

End Date

July 1 2015

Last Update

September 16 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Reliant Medical Group

Worcester, Massachusetts, United States, 01605